BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,666 | -16.7% | 14,909 | +0.6% | 0.14% | -16.0% |
| Q2 2023 | $675,381 | +12.3% | 14,824 | 0.0% | 0.16% | +5.2% |
| Q1 2023 | $601,261 | -20.4% | 14,824 | 0.0% | 0.16% | -25.1% |
| Q4 2022 | $755,579 | -8.4% | 14,824 | -3.2% | 0.21% | -16.9% |
| Q3 2022 | $825,000 | -16.2% | 15,321 | 0.0% | 0.25% | -14.1% |
| Q2 2022 | $984,000 | -17.2% | 15,321 | 0.0% | 0.29% | -9.4% |
| Q1 2022 | $1,188,000 | -9.7% | 15,321 | 0.0% | 0.32% | -8.8% |
| Q4 2021 | $1,315,000 | +6.7% | 15,321 | 0.0% | 0.35% | -10.5% |
| Q3 2021 | $1,232,000 | -0.1% | 15,321 | 0.0% | 0.39% | +4.3% |
| Q2 2021 | $1,233,000 | -4.6% | 15,321 | 0.0% | 0.38% | -9.0% |
| Q1 2021 | $1,292,000 | +5.1% | 15,321 | 0.0% | 0.41% | +9.0% |
| Q4 2020 | $1,229,000 | -0.2% | 15,321 | 0.0% | 0.38% | -15.6% |
| Q3 2020 | $1,232,000 | -9.4% | 15,321 | -3.0% | 0.45% | -19.0% |
| Q2 2020 | $1,360,000 | +5.6% | 15,801 | -0.4% | 0.55% | -12.5% |
| Q1 2020 | $1,288,000 | -5.6% | 15,859 | -2.8% | 0.63% | +1.1% |
| Q4 2019 | $1,364,000 | -4.4% | 16,316 | 0.0% | 0.63% | -11.5% |
| Q3 2019 | $1,427,000 | +4.6% | 16,316 | -2.1% | 0.71% | -13.7% |
| Q2 2019 | $1,364,000 | +0.7% | 16,660 | 0.0% | 0.82% | -3.3% |
| Q1 2019 | $1,355,000 | +23.5% | 16,660 | 0.0% | 0.85% | +1.8% |
| Q4 2018 | $1,097,000 | -17.5% | 16,660 | -3.4% | 0.83% | -6.7% |
| Q3 2018 | $1,329,000 | +3.2% | 17,246 | -1.1% | 0.89% | -7.9% |
| Q2 2018 | $1,288,000 | +12.9% | 17,446 | -0.6% | 0.97% | +4.1% |
| Q1 2018 | $1,141,000 | +0.6% | 17,546 | 0.0% | 0.93% | -19.1% |
| Q4 2017 | $1,134,000 | – | 17,546 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |